RT Journal Article
SR Electronic
T1 Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers at the onset of the U.S. COVID-19 epidemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.20.20072470
DO 10.1101/2020.04.20.20072470
A1 Barrett, Emily S.
A1 Horton, Daniel B.
A1 Roy, Jason
A1 Gennaro, Maria Laura
A1 Brooks, Andrew
A1 Tischfield, Jay
A1 Greenberg, Patricia
A1 Andrews, Tracy
A1 Jagpal, Sugeet
A1 Reilly, Nancy
A1 Blaser, Martin J.
A1 Carson, Jeffrey L.
A1 Panettieri, Reynold A.
YR 2020
UL http://medrxiv.org/content/early/2020/04/24/2020.04.20.20072470.abstract
AB Importance Healthcare workers are presumed to be at increased risk of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection due to occupational exposure to infected patients. However, no epidemiological study has examined the prevalence of SARS-CoV-2 infection in a cohort of healthcare workers during the early phase of community transmission.Objective To determine the baseline prevalence of SARS-CoV-2 infection in a cohort of previously undiagnosed healthcare workers and a comparison group of non-healthcare workers.Design Prospective cohort studySetting A large U.S. university and two affiliated university hospitalsParticipants 546 health care workers and 283 non-health care workers with no known prior SARS-CoV-2 infectionExposure Healthcare worker status and roleMain outcome(s) and measure(s) SARS-CoV-2 infection status as determined by presence of SARS-CoV-2 RNA in oropharyngeal swabs.Results At baseline, 41 (5.0%) of participants tested positive for SARS-CoV-2 infection, of whom 14 (34.2%) reported symptoms. The prevalence of SARS-CoV-2 infection was higher among healthcare workers (7.3%) than in non-healthcare workers (0.4%), representing a 7.0% greater absolute risk (95% confidence interval for risk difference 4.7%, 9.3%). The majority of infected healthcare workers (62.5%) worked as nurses. Positive tests increased across the two weeks of cohort recruitment in line with rising confirmed cases in the hospitals and surrounding counties.Conclusions and relevance In a prospective cohort conducted in the early phases of community transmission, healthcare workers had a higher prevalence of SARS-CoV-2 infection than non-healthcare workers, attesting to the occupational hazards of caring for patients in this crisis. Baseline data reported here will enable us to monitor the spread of infection and examine risk factors for transmission among healthcare workers. These results will inform optimal strategies for protecting the healthcare workforce, their families, and their patients.Clinicaltrials.gov registration number:NCT04336215Question Among previously undiagnosed individuals, is the prevalence of SARS-CoV-2 infection higher in U.S. healthcare workers compared to non-healthcare workers in the early phase of the U.S. COVID-19 epidemic?Findings The prevalence of SARS-CoV-2 infection was 7.3% in healthcare workers and 0.4% in non-healthcare workers, representing 7.0% greater absolute risk in the former (95% confidence interval for risk difference 4.7%, 9.3%). Infections were most common among nursing staff.Meaning Health care workers, particularly those with high levels of close patient contact, may be particularly vulnerable to SARS-CoV-2 infection. Additional strategies are needed to protect these critical frontline workers.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04336215Funding StatementThis work was funded by: U01AI122285, U01HL133817, UL1TR003017 NCATS, UH3AI122309, P30ES005022, R01HL149450, K23AR070286 from the National Institutes of Health.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData may be made available to potential collaborators once the primary analyses have been completed by the study team.